39 CCA patients (IHCC, EHCC, gallbladder) with IHC3+ and/or amplification via (HER2:CEP17 ratio >2 or HER2 copy number > 6) or NSG upregulated. This evidence concerns the gene ERBB2 and cholangiocarcinoma.